Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Novel drug candidates98.43M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
Rest of world97.05M98.60%
United States1.38M1.40%